Article info
PDFCorrespondence
Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab
- Correspondence to Professor Jérôme Avouac, Department of Rheumatology, Paris Descartes University, Cochin Hospital, Paris 75014, France; javouac{at}me.com
Citation
Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab
Publication history
- Received May 4, 2020
- Accepted May 5, 2020
- First published June 5, 2020.
Online issue publication
March 06, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage